Is the use of albumin in colloid prime solution of cardiopulmonary bypass circuit justified? Ricardo H Boks, BS, Lex A van Herwerden, MD, PhD, Johanna J.M Takkenberg, MD, Willem van Oeveren, PhD, Y.John Gu, PhD, Marianne J Wijers, Ad J.J.C Bogers, MD, PhD The Annals of Thoracic Surgery Volume 72, Issue 3, Pages 850-853 (September 2001) DOI: 10.1016/S0003-4975(01)02816-8
Fig 1 Example of oxygenator resistance monitored in patient 1A by the operating room data integration system. (CPB = cardiopulmonary bypass.) The Annals of Thoracic Surgery 2001 72, 850-853DOI: (10.1016/S0003-4975(01)02816-8)
Fig 2 Average resistance during cardiopulmonary bypass of the study groups in the normothermia and hypothermia periods. Values are expressed as mean ± standard deviation. The Annals of Thoracic Surgery 2001 72, 850-853DOI: (10.1016/S0003-4975(01)02816-8)
Fig 3 Beta-thromboglobulin levels during cardiopulmonary bypass for the study groups. Values are expressed as mean ± standard error of the mean computed by repeated measurement for multiple groups. The Annals of Thoracic Surgery 2001 72, 850-853DOI: (10.1016/S0003-4975(01)02816-8)
Fig 4 Prothrombin F1.2 levels during cardiopulmonary bypass for the study groups. Values are expressed as mean ± standard error of the mean computed by repeated measurement for multiple groups. The Annals of Thoracic Surgery 2001 72, 850-853DOI: (10.1016/S0003-4975(01)02816-8)